P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e691267e-n/a
Main Authors: Dickinson, Michael, Berkahn, Leanne, Trotman, Judith, Butler, Jason, Neeson, Paul, Bressel, Matthias, Minson, Adrian
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000971160.69126.7e